These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
466 related articles for article (PubMed ID: 11522182)
1. HIV type 1 Tat inhibits tumor necrosis factor alpha-induced repression of tumor necrosis factor receptor p55 and amplifies tumor necrosis factor alpha activity in stably tat-transfected HeLa Cells. Chiao C; Bader T; Stenger JE; Baldwin W; Brady J; Barrett JC AIDS Res Hum Retroviruses; 2001 Aug; 17(12):1125-32. PubMed ID: 11522182 [TBL] [Abstract][Full Text] [Related]
2. Enhanced nuclear factor-kappa B activation induced by tumour necrosis factor-alpha in stably tat-transfected cells is associated with the presence of cell-surface-bound Tat protein. Ramazzotti E; Vignoli M; Re MC; Furlini G; La Placa M AIDS; 1996 May; 10(5):455-61. PubMed ID: 8724035 [TBL] [Abstract][Full Text] [Related]
3. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. Börset M; Medvedev AE; Sundan A; Espevik T Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor induces lipopolysaccharide tolerance in a human adenocarcinoma cell line mainly through the TNF p55 receptor. Laegreid A; Thommesen L; Jahr TG; Sundan A; Espevik T J Biol Chem; 1995 Oct; 270(43):25418-25. PubMed ID: 7592709 [TBL] [Abstract][Full Text] [Related]
5. HIV-1 Tat potentiates TNF-induced NF-kappa B activation and cytotoxicity by altering the cellular redox state. Westendorp MO; Shatrov VA; Schulze-Osthoff K; Frank R; Kraft M; Los M; Krammer PH; Dröge W; Lehmann V EMBO J; 1995 Feb; 14(3):546-54. PubMed ID: 7859743 [TBL] [Abstract][Full Text] [Related]
6. Iron chelation decreases human immunodeficiency virus-1 Tat potentiated tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. Shatrov VA; Boelaert JR; Chouaib S; Dröge W; Lehmann V Eur Cytokine Netw; 1997 Mar; 8(1):37-43. PubMed ID: 9110146 [TBL] [Abstract][Full Text] [Related]
7. Down-modulation of cell surface expression of p80 form of the tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Pocsik E; Higuchi M; Aggarwal BB Lymphokine Cytokine Res; 1992 Dec; 11(6):317-25. PubMed ID: 1335762 [TBL] [Abstract][Full Text] [Related]
8. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells. Kelly GD; Morris CB; Offermann MK Virology; 1999 Oct; 263(1):128-38. PubMed ID: 10544088 [TBL] [Abstract][Full Text] [Related]
9. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells. Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842 [TBL] [Abstract][Full Text] [Related]
10. Transdominant mutants of I kappa B alpha block Tat-tumor necrosis factor synergistic activation of human immunodeficiency virus type 1 gene expression and virus multiplication. Beauparlant P; Kwon H; Clarke M; Lin R; Sonenberg N; Wainberg M; Hiscott J J Virol; 1996 Sep; 70(9):5777-85. PubMed ID: 8709193 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor receptor p55 mediates induction of HIV type 1 expression in chronically infected U1 cells. Edfjäll C; Jacobsen H; Lötscher H; Mous J AIDS Res Hum Retroviruses; 1996 Feb; 12(3):199-204. PubMed ID: 8835197 [TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. Peraldi P; Hotamisligil GS; Buurman WA; White MF; Spiegelman BM J Biol Chem; 1996 May; 271(22):13018-22. PubMed ID: 8662983 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication. Popik W; Pitha PM Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218 [TBL] [Abstract][Full Text] [Related]
14. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities. Medvedev AE; Sundan A; Espevik T Eur J Immunol; 1994 Nov; 24(11):2842-9. PubMed ID: 7957575 [TBL] [Abstract][Full Text] [Related]
15. TNF-alpha-induced growth suppression of CD34+ myeloid leukemic cell lines signals through TNF receptor type I and is associated with NF-kappa B activation. Hu X; Tang M; Fisher AB; Olashaw N; Zuckerman KS J Immunol; 1999 Sep; 163(6):3106-15. PubMed ID: 10477576 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional up-regulation of interleukin 4 receptors by human immunodeficiency virus type 1 tat gene. Husain SR; Leland P; Aggarwal BB; Puri RK AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1349-59. PubMed ID: 8891114 [TBL] [Abstract][Full Text] [Related]
17. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Amrani Y; Panettieri RA; Frossard N; Bronner C Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222 [TBL] [Abstract][Full Text] [Related]
18. Block of Tat-mediated transactivation of tumor necrosis factor beta gene expression by polymeric-TAR decoys. Brother MB; Chang HK; Lisziewicz J; Su D; Murty LC; Ensoli B Virology; 1996 Aug; 222(1):252-6. PubMed ID: 8806505 [TBL] [Abstract][Full Text] [Related]
19. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human immunodeficiency virus type 1 replication in vitro by a novel combination of anti-Tat single-chain intrabodies and NF-kappa B antagonists. Mhashilkar AM; Biswas DK; LaVecchio J; Pardee AB; Marasco WA J Virol; 1997 Sep; 71(9):6486-94. PubMed ID: 9261367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]